Theravance Biopharma Inc (TBPH)
EBITDA
$839.00K
Quarterly · Period ending: · USD
TBPH EBITDA
Latest reported$839.00Kperiod ending
Latest reported$839.00Kperiod ending
TBPH Quarterly EBITDA (-$31.82M → $839.00K)
Quarterly EBITDA
High-resolution chart · PNG
TBPH ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 839,000 | |
| -5,635,000 | |
| 75,158,000 | |
| -1,680,000 | |
| 74,796,000 | |
| -12,443,000 | |
| -7,601,000 | |
| -8,513,000 | |
| -11,775,000 | |
| -8,594,000 | |
| -5,180,000 | |
| -5,635,000 | |
| -14,030,000 | |
| -22,360,000 | |
| -11,677,001 | |
| -11,926,000 | |
| -18,187,000 | |
| -26,576,000 | |
| -35,406,000 | |
| -49,235,000 | |
| -38,157,001 | |
| -81,599,000 | |
| -75,359,000 | |
| -59,993,000 | |
| -49,202,000 | |
| -70,620,000 | |
| -56,414,000 | |
| -53,996,000 | |
| -30,222,000 | |
| -62,969,000 | |
| -48,513,000 | |
| -57,337,000 | |
| -44,681,000 | |
| -61,906,000 | |
| -76,779,000 | |
| -62,923,000 | |
| -62,720,000 | |
| -56,716,000 | |
| -57,403,000 | |
| -32,359,000 | |
| -47,043,000 | |
| -40,943,000 | |
| -55,077,000 | |
| -42,375,000 | |
| -44,698,000 | |
| -37,151,000 | |
| -64,972,000 | |
| -48,987,000 | |
| -56,020,000 | |
| -59,286,000 | |
| -43,386,000 | |
| -40,521,000 | |
| -38,253,000 | |
| -31,471,000 | |
| -28,440,000 | |
| -31,817,000 |